DE60139389D1 - Vorrichtung und methode zur behandlung von urininkontinenz bei frauen - Google Patents

Vorrichtung und methode zur behandlung von urininkontinenz bei frauen

Info

Publication number
DE60139389D1
DE60139389D1 DE60139389T DE60139389T DE60139389D1 DE 60139389 D1 DE60139389 D1 DE 60139389D1 DE 60139389 T DE60139389 T DE 60139389T DE 60139389 T DE60139389 T DE 60139389T DE 60139389 D1 DE60139389 D1 DE 60139389D1
Authority
DE
Germany
Prior art keywords
ring
oxybutynin
urinine
continence
women
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60139389T
Other languages
English (en)
Inventor
Anu Mahashabde
Martha Francine Kay
Donald F Koelmel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Womens Health Inc
Original Assignee
Duramed Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duramed Pharmaceuticals Inc filed Critical Duramed Pharmaceuticals Inc
Application granted granted Critical
Publication of DE60139389D1 publication Critical patent/DE60139389D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Materials For Medical Uses (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
DE60139389T 2000-03-21 2001-03-21 Vorrichtung und methode zur behandlung von urininkontinenz bei frauen Expired - Lifetime DE60139389D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/531,856 US6436428B1 (en) 2000-03-21 2000-03-21 Device and method for treating urinary incontinence in females
PCT/US2001/008978 WO2001070154A1 (en) 2000-03-21 2001-03-21 Device and method for treating urinary incontinence in females

Publications (1)

Publication Number Publication Date
DE60139389D1 true DE60139389D1 (de) 2009-09-10

Family

ID=24119337

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60139389T Expired - Lifetime DE60139389D1 (de) 2000-03-21 2001-03-21 Vorrichtung und methode zur behandlung von urininkontinenz bei frauen

Country Status (13)

Country Link
US (2) US6436428B1 (de)
EP (2) EP1278494B1 (de)
JP (3) JP5265836B2 (de)
AT (1) ATE437630T1 (de)
AU (2) AU2001245901B2 (de)
BR (1) BR0109691A (de)
CA (1) CA2403475C (de)
DE (1) DE60139389D1 (de)
ES (1) ES2332262T3 (de)
HK (1) HK1053254A1 (de)
IL (2) IL151858A0 (de)
MX (1) MXPA02009358A (de)
WO (1) WO2001070154A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436428B1 (en) * 2000-03-21 2002-08-20 Enhance Pharmaceuticals, Inc. Device and method for treating urinary incontinence in females
MX2013000002A (es) * 2001-07-27 2013-04-29 Teva Womens Health Inc Metodos de tratamiento de condiciones patologicas asociadas con vejiga hiperactiva.
WO2003017971A1 (en) * 2001-08-31 2003-03-06 Schering Oy Drug delivery system
PL370889A1 (en) * 2001-12-20 2005-05-30 Femmepharma, Inc. Vaginal delivery of drugs
DE10224556A1 (de) * 2002-05-31 2004-01-08 Grünenthal GmbH 1-Dimethylamino- 3-(3-methoxy-phenyl)2-methyl-pentan-3-ol entaltendes Arzneimittel in verschiedenen Formulierungen
FR2843303B1 (fr) * 2002-08-07 2006-01-21 R & D Pharma Nouvelles compositions pharmaceutiques destinees au traitement de l'incontinence urinaire
US6676594B1 (en) 2002-09-18 2004-01-13 Kimberly-Clark Worldwide, Inc. C-shaped vaginal incontinence insert
US6770025B2 (en) 2002-09-18 2004-08-03 Kimberly-Clark Worldwide, Inc. Molar shaped vaginal incontinence insert
US7263999B2 (en) * 2002-10-30 2007-09-04 Kabushiki Kaisha Kitazato Supply Ring for preventing prolapse of uterus and urinary bladder and ring for preventing prolapse of uterus and rectum
US6808485B2 (en) 2002-12-23 2004-10-26 Kimberly-Clark Worldwide, Inc. Compressible resilient incontinence insert
US9173836B2 (en) 2003-01-02 2015-11-03 FemmeParma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
CA2764405A1 (en) * 2003-01-02 2004-07-22 Femmepharma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
US8007568B2 (en) * 2006-04-12 2011-08-30 Millipore Corporation Filter with memory, communication and pressure sensor
US10219884B2 (en) 2006-07-10 2019-03-05 First Quality Hygienic, Inc. Resilient device
US8177706B2 (en) 2006-07-10 2012-05-15 Mcneil-Ppc, Inc. Method of treating urinary incontinence
CA2657138C (en) 2006-07-10 2014-08-26 Mcneil-Ppc, Inc. Resilient device
US8613698B2 (en) 2006-07-10 2013-12-24 Mcneil-Ppc, Inc. Resilient device
US10004584B2 (en) 2006-07-10 2018-06-26 First Quality Hygienic, Inc. Resilient intravaginal device
EP2104489A2 (de) * 2006-12-26 2009-09-30 FemmePharma Holding Company, Inc. Topische verabreichung von danazol
CN105581976A (zh) 2007-06-26 2016-05-18 沃纳奇尔科特有限责任公司 用于递送大分子和水溶性药物的阴道内药物递送装置
US20110003000A1 (en) * 2009-07-06 2011-01-06 Femmepharma Holding Company, Inc. Transvaginal Delivery of Drugs
US20110028922A1 (en) * 2009-07-31 2011-02-03 Kay Dennis M Female External Incontinence Device
MX2013000003A (es) * 2010-06-22 2013-04-29 Teva Womens Health Inc Dispositivos intravaginales que comprenden agentes anticolinergicos y metodos para prepararlos.
MX2013002016A (es) * 2010-08-20 2013-03-25 Teva Womens Health Inc Dispositivos intravaginales, metodos de fabricacion y usos de los mismos.
WO2012119059A1 (en) * 2011-03-03 2012-09-07 Allergan, Inc. Non-aqueous silicone-based ophthalmic formulations
CN107405299A (zh) * 2015-01-30 2017-11-28 里加利私人有限公司 阴道药物递送装置
WO2019084469A1 (en) 2017-10-27 2019-05-02 Renovia Inc. DEVICES, SYSTEMS, AND METHODS FOR PELVIC FLOOR MUSCLE TRAINING

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4286587A (en) 1978-10-11 1981-09-01 Alza Corporation Vaginal drug delivery system made from polymer
US4402695A (en) 1980-01-21 1983-09-06 Alza Corporation Device for delivering agent in vagina
ZA857643B (en) * 1984-10-12 1986-05-28 Akzo Nv Release system for two or more active substances
US4846844A (en) * 1987-08-31 1989-07-11 Eli Lilly And Company Antimicrobial coated implants
DE69326848T2 (de) 1992-05-13 2000-01-27 Alza Corp Oxybutynin zur transdermalen Verabreichung
US5900250A (en) 1992-05-13 1999-05-04 Alza Corporation Monoglyceride/lactate ester permeation enhancer for oxybutnin
JP3066515B2 (ja) * 1992-11-11 2000-07-17 久光製薬株式会社 尿失禁治療用経皮投与製剤
KR100195873B1 (ko) 1994-03-07 1999-06-15 챨스 디 에버트 약물을 포함하는 접착성 복합 경피수송 장치
US5635203A (en) 1994-09-29 1997-06-03 Alza Corporation Transdermal device having decreased delamination
US5677346A (en) 1995-01-31 1997-10-14 Sepracor, Inc. Treating urinary incontinence using (S)-desethyloxybutynin
US5532278A (en) 1995-01-31 1996-07-02 Sepracor, Inc. Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
US5601839A (en) 1995-04-26 1997-02-11 Theratech, Inc. Triacetin as a penetration enhancer for transdermal delivery of a basic drug
US5912268A (en) 1995-05-22 1999-06-15 Alza Corporation Dosage form and method for treating incontinence
US5674895A (en) 1995-05-22 1997-10-07 Alza Corporation Dosage form comprising oxybutynin
US5785991A (en) 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
US5789442A (en) * 1996-01-18 1998-08-04 Schering Aktiengesellschaft Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents
US6171298B1 (en) 1996-05-03 2001-01-09 Situs Corporation Intravesical infuser
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
KR20010029519A (ko) 1996-09-19 2001-04-06 이곤 이 버그 요실금 치료 방법
DE19812413C1 (de) * 1998-03-20 1999-06-10 Sanol Arznei Schwarz Gmbh Transdermales Therapeutisches System (TTS) Oxybutynin enthaltend
US6087396A (en) 1998-10-05 2000-07-11 Situs Corporation Oxybutynin formulations and method of use
WO2000019997A1 (en) 1998-10-07 2000-04-13 Alza Corporation Controlled release dosage from comprising oxybutynin
US6056976A (en) * 1998-11-12 2000-05-02 Leiras Oy Elastomer, its preparation and use
US6436428B1 (en) * 2000-03-21 2002-08-20 Enhance Pharmaceuticals, Inc. Device and method for treating urinary incontinence in females
ATE497745T1 (de) * 2004-07-09 2011-02-15 Population Council Inc Zusammensetzungen mit verzögerter freisetzung mit progesteron-rezeptormodulatoren

Also Published As

Publication number Publication date
IL151858A (en) 2009-12-24
US6436428B1 (en) 2002-08-20
JP5986149B2 (ja) 2016-09-06
EP1278494A1 (de) 2003-01-29
AU4590101A (en) 2001-10-03
US20020090390A1 (en) 2002-07-11
CA2403475C (en) 2011-02-08
EP2106785A1 (de) 2009-10-07
CA2403475A1 (en) 2001-09-27
JP2003527404A (ja) 2003-09-16
JP2013107895A (ja) 2013-06-06
EP2106785B1 (de) 2016-12-07
HK1053254A1 (en) 2003-10-17
WO2001070154A9 (en) 2001-12-20
EP1278494B1 (de) 2009-07-29
MXPA02009358A (es) 2003-09-25
EP1278494A4 (de) 2005-11-02
IL151858A0 (en) 2003-04-10
WO2001070154A1 (en) 2001-09-27
JP5265836B2 (ja) 2013-08-14
JP5675865B2 (ja) 2015-02-25
ES2332262T3 (es) 2010-02-01
AU2001245901B2 (en) 2004-10-07
JP2014210802A (ja) 2014-11-13
BR0109691A (pt) 2003-06-10
ATE437630T1 (de) 2009-08-15

Similar Documents

Publication Publication Date Title
DE60139389D1 (de) Vorrichtung und methode zur behandlung von urininkontinenz bei frauen
NO20065380L (no) Anvendelse av R-(+)-2-(3-diisopropylamino-l-fenylpropyl)-4-hydroksymetyl-fenylisosmorsyrehydrogenfumarat for fremstilling av et medikament for behandling av urininkontinens og andre spasmogeniske sykdommer.
DE60141145D1 (de)
BR0112361A (pt) Métodos para tratamento de condições oculares mediadas por inflamação
DE60220858D1 (de) Intravaginalvorrichtung zur Verhinderung von weiblicher Harninkontinenz
JP2003527404A5 (de)
HUP0003784A2 (hu) Fájdalmas menstruáció és koraszülés kezelésére alkalmas gyógyászati készítmény
NZ509894A (en) A "T" or "Y" shaped intravaginal device suitable for delivery of pharmaceuticals such as progesterone
HK1047707A1 (zh) (+)-曲馬朵、o-去甲曲馬朵或(+)-o-去甲曲馬朵、o-去甲-n-單-去甲-曲馬朵或(+)-o-去甲-n-單-去甲-曲馬朵治療尿失禁的用途
BR0014146A (pt) Aparelho e método para anestesiar a região cervical de uma fêmea
MXPA04003977A (es) Baja concentracion de peroxido para tratamiento o prevencion de infecciones vaginales.
ATE415953T1 (de) Vorrichtung zur wirkstofffreisetzung mit einer netzhülse
BRPI0408126B8 (pt) implante para lábios
ATE326199T1 (de) Vorrichtung zur gleichzeitigen austragung von wirkstoffen in den cervikal- und vaginalkanal
GB9227123D0 (en) Method
DE60206888D1 (de) Harninkontinenzvorrichtung
HUP0002151A2 (hu) Transzuretrális eszköz
Toeplitz et al. RHINOSCLEROMA.
JPH0728935U (ja) 性病予防液
ATE203671T1 (de) Imidazolochinoxalinone zur behandlung zentralnervöser erkrankungen
UA43128A (uk) Спосіб профілактики післяопераційних ускладнень рецидивних вентральних гриж
UA32061A (uk) Спосіб хірургічного лікування вторинної глаукоми
UA37738A (uk) Спосіб профілактики та лікування ускладнень гестагенної терапії та контрацепції
UA39559A (uk) Спосіб лікування кандидозного вульвовагініту
GEU2000739Y (en) Means for Stimulating of Spermatogenesis Oligokrin

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1278494

Country of ref document: EP

Representative=s name: MARKS & CLERK (LUXEMBOURG) LLP, LUXEMBOURG, LU